首页|良性肺部疾病患者SHOX2和RASSF1A基因甲基化的意义

良性肺部疾病患者SHOX2和RASSF1A基因甲基化的意义

扫码查看
目的 分析良性肺部疾病患者石蜡样本中SHOX2和RASSF1A甲基化状态并探讨其临床意义.方法 研究选取了本院2018-2019年确诊为良性肺部疾病的44例患者存档样本,其中包括31例石蜡组织样本和13例细胞块样本.通过实时荧光PCR检测SHOX2和RASSF1A基因的甲基化情况,并对阳性结果进行电话随访,随访时间为3年,随访终点为临床确诊肺癌.结果 所选样本中SHOX2甲基化阳性率(29.27%)显著高于RASSF1A甲基化阳性率(4.88%),差异具有统计学意义(P<0.05).组织样本中SHOX2甲基化阳性率(32.26%)显著高于RASSF1A甲基化阳性率(3.23%),差异具有统计学意义(P<0.05).比较组织样本与细胞块样本中甲基化阳性率,发现前者甲基化阳性率(35.48%)略高于后者(20.00%).组织样本中未出现两基因同时阳性结果,细胞块样本中则有1例为两基因同时阳性.SHOX2和RASSF1A甲基化结果与病理类型差异均无统计学意义(P>0.05).对11例甲基化阳性患者进行电话随访,其中1例患者后经临床确诊为肺癌.结论 在良性肺部疾病患者中有SHOX2和RASSF1A甲基化阳性的情况存在,且随访后发现有患者发展成肺癌.因此良性肺部疾病患者DNA甲基化检测结果为阳性时,结合临床特征,需进行随访,有利于对可能存在的肿瘤进展早发现、早治疗.
Significance of methylation of SHOX2 and RASSF1A genes in patients with benign lung disease
Objective To analyze the methylation status of SHOX2 and RASSF1A in paraffin samples of patients with benign lung diseases and explore their clinical significance.Methods This study selected 44 patients diagnosed with benign lung diseases from West China Hospital of Sichuan University from 2018 to 2019 as archive samples,including 31 paraffin tissue samples and 13 cell block samples.Real time fluorescence PCR was used to detect methylation of SHOX2 and RASSF1A genes,and positive results were followed up by telephone for a period of 3 years,with the endpoint being clinically confirmed lung cancer.Results The positive rate of SHOX2 methylation in the selected samples(29.27%)was significantly higher than that of RASSF1A methylation(4.88%),and the difference was statistically significant(P<0.05).The positive rate of SHOX2 methylation in organizational samples(32.26%)was significantly higher than that of RASSF1A methylation(3.23%),and the difference was statistically significant(P<0.05).Comparing the methylation positivity rate between tissue samples and cell block samples,it was found that the former had a slightly higher methylation positivity rate(35.48%)than the latter(20.00%).There was no simultaneous positive result for both genes in the organizational sample,while there was one case in the cell block sample where both genes were simulta-neously positive.There was no statistically significant difference between the methylation results of SHOX2 and RASSF1A and the pathological type(P>0.05).Telephone follow-up was conducted on 11 methylation positive patients,of which 1 patient was clinically diagnosed with lung cancer.Conclusion SHOX2 and RASSF1A methylation positive cases exist in patients with benign lung diseases,and follow-up revealed that some patients have developed lung cancer.Therefore,when the DNA methylation test result is positive in patients with benign lung diseases,combined with clinical characteristics,follow-up is necessary,which is conducive to early detection and treatment of possible tumor progression.

MethylationSHOX2RASSF1Benign lung diseaseLung cancer

张亚靖、李昱立、邱丽、郑可、张桂萍、廖殿英、唐源

展开 >

四川大学华西医院病理科,四川成都 610041

甲基化 SHOX2 RASSF1 良性肺部疾病 肺癌

2025

西部医学
四川

西部医学

影响因子:1.352
ISSN:1672-3511
年,卷(期):2025.37(1)